Catecholamines and Neurologic Diseases
- 1 January 1970
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 282 (1) , 45-46
- https://doi.org/10.1056/nejm197001012820112
Abstract
Nature has been unusually kind to research scientists who work with the catecholamines: it has endowed their work with instant relevance. In few other areas of biomedical science has it been possible to achieve so rapid a translation of basic biochemistry into practical therapy.For at least a decade, studies about the synthesis and metabolism of norepinephrine in laboratory animals have yielded enough information to allow biochemists and pharmacologists to invent chemical structures that should and do act on "noradrenergic neurons" in the human brain and sympathetic nervous system to elevate or depress mood or blood pressure.1 The results of . . .Keywords
This publication has 4 references indexed in Scilit:
- The metabolism of orally administered l‐DOPA in ParkinsonismBritish Journal of Pharmacology, 1969
- Modification of Parkinsonism — Chronic Treatment with L-DopaNew England Journal of Medicine, 1969
- Metabolic fate of L-[14C] DOPA in cerebrospinal fluid and blood plasma of humansBrain Research, 1967
- Aromatic Amino Acids and Modification of ParkinsonismNew England Journal of Medicine, 1967